Divis Laboratories P/B Ratio
Divis Laboratories (DIVISLAB) P/B ratio is 12.76 (High), book value per share ₹3162.45 vs Healthcare average P/B of -0.25 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Divis Laboratories stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
DIVISLAB P/B Ratio — Valuation Insights & Book Value Analysis
Divis Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 12.76 (High). Review DIVISLAB earnings multiple to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 12.76, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 510.5% above historical average
- Trading at premium to sector average PB of -0.25
Divis Laboratories P/B Ratio Historical Trend
DIVISLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Divis Laboratories yearly highs lows for the annual high/low range and current price position.
DIVISLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Divis Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.65 | ₹3162.45 | ₹8388.00 | ₹16,761 | Moderate |
| 2025 | 2.26 | ₹2824.34 | ₹6392.50 | ₹14,969 | Moderate |
| 2024 | 2.38 | ₹2560.57 | ₹6098.80 | ₹13,571 | Moderate |
| 2023 | 1.62 | ₹2408.87 | ₹3903.90 | ₹12,767 | Moderate |
| 2022 | 1.54 | ₹2212.83 | ₹3413.20 | ₹11,728 | Moderate |
DIVISLAB vs Healthcare Peers — P/B Ratio Comparison
Divis Laboratories P/B 12.76 vs Healthcare average -0.25, median 0.53 — range -12.29–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -12.29 | ₹15 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.6 | ₹38 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.04 | ₹66 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.7 | ₹116 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.17 | ₹41 | Low |